Review: could Vesicare cause Multiple Sclerosis Relapse?


Multiple sclerosis relapse is found among people who take Vesicare, especially for people who are female, 50-59 old , have been taking the drug for 1 - 6 months, also take medication Ampyra, and have Multiple sclerosis . We study 15,743 people who have side effects while taking Vesicare from FDA and social media. Among them, 165 have Multiple sclerosis relapse. Find out below who they are, when they have Multiple sclerosis relapse and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. (latest outcomes from Vesicare 16,350 users)

Multiple Sclerosis Relapse

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) has been reported by people with multiple sclerosis, relapsing-remitting multiple sclerosis, gait disturbance, depression, pain (latest reports from 40,883 Multiple sclerosis relapse patients).

On Oct, 23, 2016

15,743 people reported to have side effects when taking Vesicare.
Among them, 165 people (1.05%) have Multiple Sclerosis Relapse

Number of reports submitted per year:

Could Vesicare cause Multiple sclerosis relapse?

Time on Vesicare when people have Multiple Sclerosis Relapse *:

  • < 1 month: 33.33 %
  • 1 - 6 months: 66.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Multiple Sclerosis Relapse when taking Vesicare *:

  • female: 84.15 %
  • male: 15.85 %

Age of people who have Multiple Sclerosis Relapse when taking Vesicare *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.43 %
  • 30-39: 9.29 %
  • 40-49: 28.57 %
  • 50-59: 37.14 %
  • 60+: 23.57 %

Top conditions involved for these people *:

  • Multiple Sclerosis (109 people, 66.06%)
  • Relapsing-Remitting Multiple Sclerosis (29 people, 17.58%)
  • Gait Disturbance (27 people, 16.36%)
  • Multiple Sclerosis Relapse (9 people, 5.45%)
  • Depression (7 people, 4.24%)

Top co-used drugs for these people *:

  • Ampyra (49 people, 29.70%)
  • Gilenya (43 people, 26.06%)
  • Tysabri (40 people, 24.24%)
  • Baclofen (34 people, 20.61%)
  • Vitamin D (26 people, 15.76%)

Top other side effects for these people *:

  • Fatigue (42 people, 25.45%)
  • Gait Disturbance (35 people, 21.21%)
  • Fall (28 people, 16.97%)
  • Paraesthesia (27 people, 16.36%)
  • Headache (26 people, 15.76%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Multiple sclerosis relapse when taking Vesicare?

Browse all side effects of Vesicare

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Multiple sclerosis relapse

Multiple sclerosis relapse

Could your condition cause Multiple sclerosis relapse

Multiple sclerosis relapse

Related studies

Can you answer these questions?

More questions for: Vesicare, Multiple sclerosis relapse

You may be interested in these reviews

More reviews for: Vesicare, Multiple sclerosis relapse

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.